Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

Beijing Hotgen Biotech Revenue

Beijing Hotgen Biotech had revenue of 151.72M CNY in the quarter ending June 30, 2026, with 37.67% growth. This brings the company's total for the last twelve months to 469.17M, up 1.03% year-over-year. In the year 2025, Beijing Hotgen Biotech had annual revenue of 404.88M, down -20.58%. That makes Beijing Hotgen Biotech the 25,382nd largest company in the world by revenue and 4,516th in China.

• Revenue (ttm): 469.17M
• Revenue Growth: +1.03%
• P/S Ratio: 13.17
• Revenue / Employee: 449.83K
• Employees: 1,043
• Market Cap: 6.37B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 373.50M 94.4%
• Overseas 21.96M 5.6%

Fiscal year ended Dec 31, 2025 See the full Beijing Hotgen Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	404.88M	-104.90M	-20.58%
Dec 31, 2024	509.78M	-38.06M	-6.95%
Dec 31, 2023	547.84M	-3.01B	-84.60%
Dec 31, 2022	3.56B	-1.81B	-33.76%
Dec 31, 2021	5.37B	4.86B	945.54%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error